Using algorithms, genetic markers, and biometric data, predictive medicine forecasts who might develop illnesses before symptoms even appear. At first glance, it sounds like a leap towards keeping people healthier for longer by catching problems early, improving care, and reducing costs.
But beneath the surface, it feels like an opportunity to monetise the
data-driven findings, and raises vital questions about fairness and
consent. Who’s at risk, and who really benefits?...<<<Read More>>>...